Literature DB >> 6411828

Homogeneity of cell envelope protein subtypes, lipopolysaccharide serotypes, and biotypes among Haemophilus influenzae type b from patients with meningitis in The Netherlands.

L van Alphen, T Riemens, J Poolman, C Hopman, H C Zanen.   

Abstract

Eighty strains of Haemophilus influenzae type b were randomly selected from 531 strains collected between 1975 and 1982 from patients with meningitis in The Netherlands. Subtyping by sodium dodecyl sulfate-polyacrylamide gel electrophoresis revealed that 67 of 80 isolates had identical major outer membrane protein patterns (subtype 1). Among the 13 other isolates four different polyacrylamide gel electrophoresis patterns were observed, two of which closely resembled subtype 1. Lipopolysaccharides were characterized immunologically by immunoprecipitation (Ouchterlony technique) and the gel-immuno-radio-assay. Four serotypes were found among the 80 selected strains, leaving one strain not typable. Seventy-four strains (93%) belonged to the same lipopolysaccharide serotype; 77 (97%) of 80 of the strains belonged to biotype I. Sixty strains (75%) had identical major outer membrane protein patterns (subtype 1), lipopolysaccharide serotypes (serotype 1), and biotypes (I).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6411828     DOI: 10.1093/infdis/148.1.75

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  43 in total

1.  Subtyping of Haemophilus influenzae strains by pulsed-field gel electrophoresis.

Authors:  M Saito; A Umeda; S i Yoshida
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

2.  Use of chromosomal gene fusions to investigate the role of repetitive DNA in regulation of genes involved in lipopolysaccharide biosynthesis in Haemophilus influenzae.

Authors:  M Szabo; D Maskell; P Butler; J Love; R Moxon
Journal:  J Bacteriol       Date:  1992-11       Impact factor: 3.490

3.  Outer membrane protein subtypes of Haemophilus influenzae type b isolates causing invasive disease in Victoria, Australia, from 1988 to 1990.

Authors:  D A Clements; S J MacInnes; G L Gilbert
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

4.  Antigenic relationships among the porin proteins of encapsulated Haemophilus influenzae clones.

Authors:  D Martin; J Hamel; B R Brodeur; J M Musser
Journal:  J Clin Microbiol       Date:  1990-08       Impact factor: 5.948

5.  Conservation of epitopes in the oligosaccharide portion of the lipooligosaccharide of Haemophilus influenzae type b.

Authors:  P A Gulig; C C Patrick; L Hermanstorfer; G H McCracken; E J Hansen
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

6.  Phase-variable lipopolysaccharide structures enhance the invasive capacity of Haemophilus influenzae.

Authors:  J N Weiser; A Williams; E R Moxon
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

7.  Molecular characteristics of Haemophilus influenzae causing invasive disease during the period of vaccination in Switzerland: analysis of strains isolated between 1986 and 1993.

Authors:  K Muhlemann; M Balz; S Aebi; K Schopfer
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

8.  Interaction of fimbriae of Haemophilus influenzae type B with heparin-binding extracellular matrix proteins.

Authors:  R Virkola; M Brummer; H Rauvala; L van Alphen; T K Korhonen
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

9.  DNA repeats identify novel virulence genes in Haemophilus influenzae.

Authors:  D W Hood; M E Deadman; M P Jennings; M Bisercic; R D Fleischmann; J C Venter; E R Moxon
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

10.  Immunological properties of recombinant porin of Haemophilus influenzae type b expressed in Bacillus subtilis.

Authors:  R Srikumar; D Dahan; M F Gras; L Saarinen; H Käyhty; M Sarvas; L Vogel; J W Coulton
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.